Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study

Table 2 Demographics and cardiovascular risk factors for RA and PsA Responders

	RA (N = 858)	PsA (N = 161)	p
	Mean (SD)	Mean (SD)
Age, years	58 (12)	55 (10)	< 0.001
Disease duration, years	18 (11)	15 (9)	0.005
	N (%)	N (%)
Female	657 (76.6)	95 (59.0)	< 0.001
University/tertiary education	504 (58.7)	101 (62.7)	0.3
Full time work or study	214 (24.9)	67 (41.6)	< 0.001
Current biologic DMARD	627 (73.1)	125 (77.6)	0.23
Current methotrexate	576 (67.1)	86 (53.4)	0.001
Current prednis(ol)one	295 (34.4)	16 (9.9)	< 0.001
Current smoker	52 (6.1)	10 (6.2)	0.9
Hypertension	279 (32.5)	53 (32.9)	0.9
Diabetes	73 (8.5)	14 (8.7)	0.9
Hyperlipidaemia	157 (18.3)	26 (16.1)	0.5
Overweight or obese	564 (66.0)	131 (81.4)	< 0.001
Physically active	418 (48.7)	83 (51.6)	0.5

RA rheumatoid arthritis, PsA psoriatic arthritis, SD standard deviation, DMARD disease modifying antirheumatic drug

ISSN: 2520-1026